[Federal Register Volume 62, Number 244 (Friday, December 19, 1997)]
[Notices]
[Page 66667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-33114]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 30, 1997, Ansys 
Diagnostics, Inc., 2 Goodyear, Irvine, California 92718, made 
application by renewal to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471)..........................................       II 
1-Piperidinocyclohexanecarbonitrile (PCC) (8603)..............       II 
Benzoylecgonine (9180)........................................       II 
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than February 17, 1998.

    Dated: December 3, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-33114 Filed 12-18-97; 8:45 am]
BILLING CODE 4410-09-M